Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eversource Energy
ES
|
+$124M |
| 2 |
Equinix
EQIX
|
+$116M |
| 3 |
QRVO
Qorvo
QRVO
|
+$92.4M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$61.4M |
| 5 |
AbbVie
ABBV
|
+$58.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$901M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$182M |
| 3 |
Monster Beverage
MNST
|
+$168M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$89.9M |
| 5 |
TGNA
TEGNA Inc
TGNA
|
+$66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.43% |
| 2 | Healthcare | 15.33% |
| 3 | Technology | 14.87% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
IBM
IBM
$214B
| $1.19B | 0.68% |
7,644,168
+97,420
| +1% | +$15.7M |
2013 Q2
8 quarters
|
|
27
Home Depot
HD
$290B
| $1.14B | 0.65% |
10,234,295
-117,145
| -1% | -$13.1M |
2013 Q2
8 quarters
|
|
28
PepsiCo
PEP
$172B
| $1.09B | 0.62% |
11,689,855
+59,929
| +0.5% | +$5.73M |
2013 Q2
8 quarters
|
|
29
Visa
V
$724B
| $1.02B | 0.58% |
15,163,943
+17,678
| +0.1% | +$1.2M |
2013 Q2
8 quarters
|
|
30
Oracle
ORCL
$429B
| $1.01B | 0.58% |
25,160,834
+110,540
| +0.4% | +$4.79M |
2013 Q2
8 quarters
|
|
31
Philip Morris
PM
$314B
| $980M | 0.56% |
12,241,918
+39,513
| +0.3% | +$3.25M |
2013 Q2
8 quarters
|
|
32
Amgen
AMGN
$224B
| $958M | 0.55% |
6,252,031
-1,067
| -0% | -$171K |
2013 Q2
8 quarters
|
|
33
CVS Health
CVS
$110B
| $937M | 0.54% |
8,954,246
-297,318
| -3% | -$30.4M |
2013 Q2
8 quarters
|
|
34
Walmart Inc
WMT
$883B
| $929M | 0.53% |
39,366,600
+478,290
| +1% | +$12.2M |
2013 Q2
8 quarters
|
|
35
UnitedHealth
UNH
$340B
| $919M | 0.52% |
7,550,120
-299,798
| -4% | -$35.5M |
2013 Q2
8 quarters
|
|
|
36
AbbVie
ABBV
$489B
| $909M | 0.52% |
13,552,821
+900,542
| +7% | +$58.8M |
2013 Q2
8 quarters
|
|
37
SLB Ltd
SLB
$72.6B
| $882M | 0.5% |
10,253,097
+321,350
| +3% | +$29M |
2013 Q2
8 quarters
|
|
38
Bristol-Myers Squibb
BMY
$121B
| $878M | 0.5% |
13,224,857
+309
| +0% | +$20.4K |
2013 Q2
8 quarters
|
|
39
Qualcomm
QCOM
$187B
| $862M | 0.49% |
13,785,162
+214,874
| +2% | +$14.7M |
2013 Q2
8 quarters
|
|
40
Medtronic
MDT
$113B
| $854M | 0.49% |
11,544,348
+42,647
| +0.4% | +$3.26M |
2013 Q2
8 quarters
|
|
41
3M
MMM
$82.5B
| $779M | 0.44% |
6,046,993
+22,838
| +0.4% | +$3.06M |
2013 Q2
8 quarters
|
|
42
Biogen
BIIB
$33.3B
| $778M | 0.44% |
1,929,721
+13,097
| +0.7% | +$5.26M |
2013 Q2
8 quarters
|
|
43
Altria Group
MO
$120B
| $768M | 0.44% |
15,735,739
+267,488
| +2% | +$13.6M |
2013 Q2
8 quarters
|
|
|
CELG
44
DELISTED
Celgene Corp
CELG
| $748M | 0.43% |
6,474,296
-38,469
| -0.6% | -$4.4M |
2013 Q2
8 quarters
|
|
45
RTX Corp
RTX
$251B
| $740M | 0.42% |
10,615,485
-2,915
| -0% | -$214K |
2013 Q2
8 quarters
|
|
46
McDonald's
MCD
$166B
| $717M | 0.41% |
7,551,939
+27,899
| +0.4% | +$2.7M |
2013 Q2
8 quarters
|
|
47
Mastercard
MA
$516B
| $709M | 0.41% |
7,604,175
+5,595
| +0.1% | +$513K |
2013 Q2
8 quarters
|
|
48
Boeing
BA
$150B
| $709M | 0.4% |
5,118,047
-91,068
| -2% | -$13.3M |
2013 Q2
8 quarters
|
|
49
Goldman Sachs
GS
$261B
| $693M | 0.4% |
3,327,383
-31,498
| -0.9% | -$6.42M |
2013 Q2
8 quarters
|
|
50
American International
AIG
$40.3B
| $664M | 0.38% |
10,754,491
-428,141
| -4% | -$25.3M |
2013 Q2
8 quarters
|
|
Similar funds
Geode Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Geode Capital Management held 4,062 positions worth $175B, up 0.12% from $175B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management's Q2 2015 filing shows 109 new, 2,831 increased, 660 reduced and 104 closed positions. Its largest new stake was Eversource Energy: 2,548,587 shares worth $116M. The largest sale was Allergan plc, an estimated $901M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Geode Capital Management's largest Q2 2015 buy was Eversource Energy: 2,548,587 shares worth $116M.
- Geode Capital Management added most to Reynolds American Inc in Q2 2015, an estimated $61.4M increase.
- Geode Capital Management's biggest Q2 2015 reduction was Apple, cutting an estimated $41.7M.
- Geode Capital Management fully exited Allergan plc in Q2 2015, selling an estimated $901M.
- Geode Capital Management's ten largest holdings make up 15% of its $175B portfolio in Q2 2015.
- Geode Capital Management opened 109 new positions and closed 104 in Q2 2015.
- Geode Capital Management's portfolio value rose 0.12% quarter-over-quarter to $175B.
Based on Geode Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.